Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FLURAZEPAM\FLURAZEPAM vs FLURBIPROFEN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FLURAZEPAM\FLURAZEPAM vs FLURBIPROFEN: Safety Overview

Metric FLURAZEPAM\FLURAZEPAM FLURBIPROFEN
Total FAERS Reports 324 647
Deaths Reported 53 27
Death Rate 16.4% 4.2%
Hospitalizations 178 292
Average Patient Age 51.3 yrs 38.4 yrs
% Female Patients 63.9% 82.8%
FDA Approval Date N/A Apr 1, 1997
Manufacturer N/A IPG Pharmaceuticals, Inc.
Route N/A ORAL
Marketing Status N/A Discontinued